SCHEMBL2490780

SCHEMBL2490780

Cc1ccccc1-c1cccc(N(C)CCO)c1-c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
HSD17B10 Q99714 4/20 0.46
USP2 O75604 3/20 0.46
CASP1 P29466 2/20 0.46
CASP7 P55210 2/20 0.46
HBB P68871 2/20 0.46
GAA P10253 1/20 0.46
CRHBP P24387 1/20 0.46
BRCA1 P38398 1/20 0.46
CRHR2 Q13324 1/20 0.46
PABPC1 P11940 1/20 0.41
SLC9A5 Q14940 1/20 0.38
HTR7 P34969 2/20 0.38
KDM4E B2RXH2 3/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491885 0.91 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL2491971 0.80 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL11702654 0.79 ALDH1A1 (0.45) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL2488726 0.78 HTR7 (0.50) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL15541234 0.76 ALDH1A1 (0.43) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL15859646 0.76 MEN1 (0.64) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL15859643 0.75 MEN1 (0.72) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL7063623 0.74 MEN1 (0.62) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL29915571 0.73 MEN1 (0.52) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL2494412 0.72 MEN1 (0.35) MEN1KMT2AALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MEN1 1585/4885KMT2A 2108/4885ALDH1A1 1292/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MEN1 1346/4885KMT2A 2219/4885ALDH1A1 1031/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MEN1 1200/4885KMT2A 2287/4885ALDH1A1 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.